BackCurative Biotechnology Overview

Curative Biotechnology Current Cash

Curative Biotechnology's current cash is $150K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$145258.00

Peer trimmed avg / median

Loading

Curative Biotechnology Current Cash History

Loading

Curative Biotechnology vs. peers: Current Cash Comparison

Loading

Curative Biotechnology Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Curative Biotechnology (CUBT) FAQ

The latest current cash for CUBT is $150K as of June 2026. Investors often review this figure alongside Curative Biotechnology's historical trend and sector peers before judging valuation or financial health.

A current cash figure of $150K for CUBT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CUBT's current cash ($150K), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.